MHRA on Senokot
This article was originally published in The Tan Sheet
A Senokot Hi-Fiber TV ad claiming consumers can take the product to "top up" their daily fiber intake in order to stay regular will be withdrawn because it is in breach of UK advertising legislation, the Medicines & Healthcare products Regulatory Agency says May 23. Senokot is "for the relief of constipation" and is "not indicated for maintenance of regularity per se in the general healthy population," MHRA explains...
You may also be interested in...
Former senior advisor to President Trump warns that failure to reform drug pricing practices has seriously handicapped prospects for reimbursing cell and gene therapy under existing US payer programs.
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.